A new research paper titled "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia" has been published in Oncotarget.
Apr 10, 2024
0
0
The hematopoietic system is a complex tissue characterized by multiple layers of stem cells, progenitor cells, and mature blood cells. Operating under normal conditions, it ensures a continuous and stable blood supply throughout ...
Apr 10, 2024
0
0
Cancer cases are increasing among young people, with rising instances of colorectal cancer in people under age 55 and cervical cancer diagnoses ticking up for women ages 33 to 44, according to the American Cancer Society.
Apr 10, 2024
0
0
A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier. The work is published in the journal Science Advances.
Apr 10, 2024
0
16
The U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.
Apr 10, 2024
0
1
Mutations are the changes in the DNA that gradually occur in human cells as they replicate, and the organism grows and ages. Some of these changes, particularly when they occur in genes, can be instrumental during the development ...
Apr 10, 2024
0
0
Throat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a type of head and neck cancer that can be divided into two subgroups: HPV-associated cancers ...
Apr 10, 2024
0
1
CAR T cell therapy has revolutionized the way certain types of cancer are treated, and the longer those CAR T cells live in a patient's body, the more effectively they respond to cancer. Now, in a new study, researchers at ...
Apr 10, 2024
0
48
Examining the immune cells in the environment around a tumor could help to predict how a person's cancer might progress and respond to treatment, according to new research led by UCL and the Francis Crick Institute.
Apr 10, 2024
0
0
Recent research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by ...
Apr 10, 2024
0
5
